The new antihistamines--desloratadine and levocetirizine: a review.
Scheinfeld
Noah
N
Department of Dermatology, St. Luke's Roosevelt Hospital Center, 1090 Amsterdam Ave Suite 11D, NY, NY 10025, USA. Scheinfeld@rcn.com
D000085:Acetates / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000818:Animals; D019540:Area Under Curve; D017332:Cetirizine; D006207:Half-Life; D039563:Histamine H1 Antagonists, Non-Sedating / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D017336:Loratadine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use*; D010879:Piperazines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D000085:Acetates; D039563:Histamine H1 Antagonists, Non-Sedating; D010879:Piperazines; C472067:levocetirizine; D017336:Loratadine; C121345:desloratadine; D017332:Cetirizine